Delta 9 Cannabis Inc.
DLTNF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.03 | 0.06 |
| FCF Yield | 75.10% | -75.78% | -11.08% | -9.35% |
| EV / EBITDA | -64.47 | -5.27 | -50.18 | 22.94 |
| Quality | ||||
| ROIC | -22.77% | -27.38% | -11.09% | -3.21% |
| Gross Margin | 20.33% | 17.21% | 27.80% | 34.58% |
| Cash Conversion Ratio | -0.25 | 0.13 | 0.07 | -0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.49% | 6.70% | 25.17% | 90.16% |
| Free Cash Flow Growth | 159.29% | -79.46% | 22.53% | 83.45% |
| Safety | ||||
| Net Debt / EBITDA | -59.91 | -4.68 | -27.18 | 8.58 |
| Interest Coverage | -1.98 | -3.11 | -1.96 | -0.65 |
| Efficiency | ||||
| Inventory Turnover | 4.19 | 2.64 | 1.99 | 1.91 |
| Cash Conversion Cycle | 80.65 | 133.95 | 185.35 | 207.03 |